Revaprazan Hydrochloride CAS 178307-42-1 Assay ≥99.0% API Factory High Purity
Igama leMichiza: iRevaprazan Hydrochloride;Revaprazan HCL
CAS: 178307-42-1
Umgangatho ophezulu we-API, iMveliso yoRhwebo
Igama leMchiza | IRevaprazan Hydrochloride |
Izithethantonye | Revaprazan HCL |
Inombolo yeCAS | 178307-42-1 |
Inombolo yeCAT | RF-API48 |
Ubume beStokhwe | Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram |
Ifomula yeemolekyuli | I-C22H24ClFN4 |
Ubunzima beMolekyuli | 398.904 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo weCrystalline oMhlophe okanye oMhlophe |
Ukunyibilika | I-soluble ngokukhululekileyo kwi-chloroform, i-dichlormeth;Inyibilika kwiAcetic acid;I-soluble kancinane kwi-methanol, i-DMSO;Kunzima ukunyibilika kwi-acetone, i-ACN;Phantse ayinakunyibilika kwisisombululo se-0.1mol/L se-NaOH.Isisombululo se-0.1mol / L HCL. |
Ukuchongwa | Kufuneka kuphendulwe kakuhle λ max 271nm, 205nm IR |
Indawo yokunyibilika | 219.0 ~ 222.0℃ |
Ukucaca kunye nombala | Kufuneka icace kwaye ingabi mbala kwi-dichlormeth |
I-Chloride | ≤8.93% |
Ukungacoceki Okukodwa | ≤0.10% |
Ukungcola ngokupheleleyo | ≤0.50% |
Ilahleko ekomisweni | ≤0.50% |
Intsalela kwi-Ignition | ≤0.10% |
Sulfate | ≤20ppm |
Arsenic | ≤10ppm |
Iintsimbi ezinzima | ≤10ppm |
Isivavanyi | ≥99.0% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | I-Active Pharmaceutical ingredient (API) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-Revaprazan Hydrochloride (CAS: 178307-42-1) enomgangatho ophezulu.I-Revaprazan Hydrochloride inciphisa ukubonakaliswa kwe-COX-2 kwaye inezenzo ezibalulekileyo zokulwa nokuvuvukala kwi-H. pylori usulelo.I-Revaprazan Hydrochloride kunyango lwesilonda se-duodenal, isilonda sesisu kunye ne-gastritis.
I-Revaprazan Hydrochloride (ekwaziwa ngokuba yi-reversible proton pump inhibitors, i-potassium ekhuphisanayo ne-acid blockers, i-p-CABs) sisizukulwana esitsha se-proton pump inhibitors kunye ne-potassium kuphela ekhuphisanayo ye-acid pump inhibitors okanye i-acid pump antagonists ehlabathini.Iphuhliswe yinkampani yaseMzantsi Korea iYuhan kunye namalungelo obunini bepropathi enomgangatho ophezulu wokuqonda, i-GLAxoSmithKline ifumene iilayisenisi zophuhliso kunye nentengiso yehlabathi jikelele yechiza ngaphandle koMzantsi Korea noMntla Korea.Ichiza lavunywa yi-FDA yaseMzantsi Korea ngo-2007 ukunyanga izilonda ze-duodenal kunye ne-gastritis.